Also found in: Medical, Wikipedia.
FOLFOX5-Fluorouracil, Leucovorin and Oxaliplatin (chemo treatment)
References in periodicals archive ?
Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy.
sup][25],[26],[27],[28] Based on our experience with different chemotherapy regimens, the FOLFOX treatment was the most effective, with a survival rate of approximately 41%.
Reasons for excluding 57 cases were: analphabetic (n=1), having a prior cancer before actual colorectal cancer (n=5), receive other psychiatric or psychological support (n=22), or be receiving the 8th to 12th sessions of the FOLFOX procedure, since this situation precluded the application of the EPEP (see Procedure section).
With this approval, Vectibix became the first-and-only biologic therapy indicated for use with FOLFOX, one of the most commonly used chemotherapy regimens, in the first-line treatment of mCRC for patients with wild-type KRAS mCRC.
In the trial, protocol Curcumin C3 Complex was tolerated well with 2 g/ day dose with standard FOLFOX chemotherapy (combination of 5-Flurouracil and Oxaliplatin, two chemotherapeutic drugs).
Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy.
The chemotherapy regimens that administered, consisted of drugs such as FOLFOX, FOLFIRI, AVASTIN, Xeloda, Oxaliplatin, 5-FU, Mitomicyn C.
It is that targeted outpatient procedure, known as Selective Internal Radiation Therapy, that Meegan received on February 22, 2005, followed by a chemotherapy regimen called FOLFOX that has provided Meegan and Peter with ten wonderful years of togetherness.
Spratlin, "CAPOX associated with toxicities of higher grade but improved disease-free survival when compared with FOLFOX in the adjuvant treatment of stage III colon cancer," Clinical Colorectal Cancer, vol.
She was then treated with FOLFOX and was switched to Gemzar and Abraxane thereafter.
At ASCO, Amgen also presented results from Phase II tests that reinforced the improved overall survival benefit of panitumumab (Vectibix) when used in combination with FOLFOX, an oxaliplatin-based chemotherapy regimen, compared to bevacizumab (Avastin) plus FOLFOX as first-line treatment in patients with wild-type RAS metastatic colorectal cancer (mCRC).
Traditional systemic therapies have been extrapolated from treatment of colorectal cancer (CRC) and, although data are limited, there have been several reports noting benefit with FOLFOX [folinic acid (leucovorin), 5-FU (fluorouracil), and oxaliplatin] therapy.